BSIM Therapeutics
Manufacturing · Portugal · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Rua Pedro Nunes, Coimbra, PortugalWebsite
www.bsimtx.comRevenue
<$5 MillionIndustry
About BSIM Therapeutics
Is BSIM Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if BSIM Therapeutics is spiking on competitors!
Check if BSIM Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once BSIM Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when BSIM Therapeutics launches new products
BSIM Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if BSIM Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at BSIM Therapeutics
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on BSIM Therapeutics recently announced quarterly report
Recommended Actions
Find VP level buyers at BSIM Therapeutics
Find more new buyers
Company Profile Activity
Activity Insights
BSIM Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BSIM Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BSIM Therapeutics.
BSIM Therapeutics Tech Stack
A closer look at the technologies used by BSIM Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BSIM Therapeutics
BSIM Therapeutics focuses on developing innovative medicines for patients affected by transthyretin amyloidoses, specifically targeting various clinical manifestations such as polyneuropathy, cardiomyopathy, and oculopathy. The company aims to improve patient lives through next-generation transthyretin stabilizers. Their recent achievements include... Read More